Vanishing cerebral vasculitis in a patient with Lewy pathology

Natalia Liapounova, Kamran H. Azar, J. Max Findlay, Jian-Qiang Lu

PDF(352 KB)
PDF(352 KB)
Journal of Biomedical Research ›› 2017, Vol. 31 ›› Issue (6) : 559-562. DOI: 10.7555/JBR.31.20160119
Case Report
Case Report

Vanishing cerebral vasculitis in a patient with Lewy pathology

Author information +
History +

Abstract

Immune-mediated mechanisms are involved in the pathogenesis of both cerebral vasculitis and Parkinson's disease (PD, brainstem-predominant Lewy pathology), but the presentation of cerebral vasculitis with comorbid Lewy pathology has not yet been reported. Here we present a case of pathologically confirmed vasculitis in a 73-year-old male patient whose postmortem examination revealed Lewy pathology diagnostic of PD. This case study suggests a comorbidity of cerebral vasculitis and Lewy pathology, as well as potential pathogenic interactions between these two disorders with immune-mediated mechanisms.

Keywords

vasculitis / cerebrovascular disease / Parkinson's disease / Lewy pathology / synucleinopathy / immune pathogenesis

Cite this article

Download citation ▾
Natalia Liapounova, Kamran H. Azar, J. Max Findlay, Jian-Qiang Lu. Vanishing cerebral vasculitis in a patient with Lewy pathology. Journal of Biomedical Research, 2017, 31(6): 559‒562 https://doi.org/10.7555/JBR.31.20160119

References

[1]
Birnbaum J, Hellmann  DB. Primary angiitis of the central nervous system[J]. Arch Neurol, 2009, 66(6): 704–709
Pubmed
[2]
Miller DV, Salvarani  C, Hunder GG , Biopsy findings in primary angiitis of the central nervous system[J]. Am J Surg Pathol, 2009, 33(1): 35–43
Pubmed
[3]
Berger JR, Romano  J, Menkin M , Benign focal cerebral vasculitis: case report[J]. Neurology, 1995, 45(9): 1731–1734
Pubmed
[4]
Dickson DW, Braak  H, Duda JE , Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria[J]. Lancet Neurol, 2009, 8(12): 1150–1157
Pubmed
[5]
Chen Z, Yang  Y, Yang X , Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson’s disease[J]. Neurol Sci, 2013, 34(9): 1559–1570
Pubmed
[6]
Brochard V, Combadière  B, Prigent A , Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease[J]. J Clin Invest, 2009, 119(1): 182–192
Pubmed
[7]
Orr CF, Rowe  DB, Halliday GM . An inflammatory review of Parkinson’s disease[J]. Prog Neurobiol, 2002, 68(5): 325–340
Pubmed
[8]
Stevens CH, Rowe  D, Morel-Kopp MC , Reduced T helper and B lymphocytes in Parkinson’s disease[J]. J Neuroimmunol, 2012, 252(1-2): 95–99
Pubmed

Acknowledgments

The authors thank Dr. Robert A. Ashforth, radiologist at the University of Alberta Hospital, for his help with interpreting MR images, and Dr. Marius Meyer, family physician in Dawson Creek, British Columbia, for the patient care and providing additional clinical information.

RIGHTS & PERMISSIONS

2017 2017 by the Journal of Biomedical Research.
PDF(352 KB)

Accesses

Citations

Detail

Sections
Recommended

/